Volume | 450 842 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 8,2986 | Bas Haut |
|||||
Minimum Bas | 7,825 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Larimar Therapeutics Inc | LRMR | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
7,98 | 7,825 | 8,2986 | 7,87 | 7,99 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
6 809 | 450 842 | US$ 8,07 | US$ 3 638 471 | - | 2,18 - 13,68 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:27:46 | 57 | US$ 7,66 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
63,16M | 63,80M | - | 0 | -36,95M | -0,58 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Larimar Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
10/6/2024 | 12:05 | Edgar (US Regulatory) | Form 8-K - Current report |
31/5/2024 | 22:57 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
31/5/2024 | 22:56 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
31/5/2024 | 22:07 | Edgar (US Regulatory) | Form 8-K - Current report |
30/5/2024 | 22:08 | Edgar (US Regulatory) | Form 8-K - Current report |
28/5/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
20/5/2024 | 22:08 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 22:50 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
09/5/2024 | 13:02 | Edgar (US Regulatory) | Form 8-K - Current report |
11/3/2024 | 21:09 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 22:06 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 02:57 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
Forum Action Larimar Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Larimar Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 9,54 | 10,20 | 7,825 | 9,02 | 352 371 | -1,67 | -17,51% |
1 mois | 8,05 | 10,20 | 6,8811 | 8,47 | 688 672 | -0,18 | -2,24% |
3 mois | 7,65 | 10,20 | 5,91 | 7,84 | 455 927 | 0,22 | 2,88% |
6 mois | 4,26 | 13,68 | 3,795 | 8,81 | 506 190 | 3,61 | 84,74% |
1 an | 3,30 | 13,68 | 2,18 | 7,42 | 345 086 | 4,57 | 138,48% |
3 ans | 8,28 | 15,2581 | 1,53 | 6,22 | 222 754 | -0,41 | -4,95% |
5 ans | 12,00 | 25,87 | 1,53 | 7,04 | 182 726 | -4,13 | -34,42% |